IL33 and inflammatory bowel disease: However, consistent evidence has also pled a more protective effect of the IL-33/ST2 axis, particularly in mucosal healing processes in IBD [63], immunosuppression in severe sepsis [64] and the reduction in the formation of atherosclerotic plaques in cardiovascular diseases [65].